2

Phase I dose-escalation oncology trials with sequential multiple schedules

We developed a method to analyse phase I dose-escalation trials with multiple schedules.

A Bayesian time-to-event pharmacokinetic model for phase I dose-escalation trials with multiple schedules

We developed a method to analysze phase I dose-escalation trials with mutiple schedules.

Shrinkage Estimation for Dose–Response Modeling in Phase II Trials With Multiple Schedules

We propose a Bayesian hierarchical model with random-effects to model the between-schedule heterogeneity with regard to certain parameters for the phase II trials with multiple schedules.

Random-effects meta-analysis of few studies involving rare events

We developed a method to for the meta-analysis of few studies involving rare events.

A design‐by‐treatment interaction model for network meta‐analysis and meta‐regression with integrated nested Laplace approximations

We developed a method to for the meta-analysis of few studies involving rare events.